| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.04 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |